Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 2
2007 1
2008 2
2009 3
2010 5
2011 4
2012 5
2013 3
2014 5
2015 3
2017 2
2018 1
2019 4
2020 5
2021 1
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Oaknin A, Gladieff L, Martínez-García J, Villacampa G, Takekuma M, De Giorgi U, Lindemann K, Woelber L, Colombo N, Duska L, Leary A, Godoy-Ortiz A, Nishio S, Angelergues A, Rubio MJ, Fariñas-Madrid L, Yamaguchi S, Lorusso D, Ray-Coquard I, Manso L, Joly F, Alarcón J, Follana P, Romero I, Lebreton C, Pérez-Fidalgo JA, Yunokawa M, Dahlstrand H, D'Hondt V, Randall LM; ENGOT-Cx10–GEICO 68-C–JGOG1084–GOG-3030 Investigators. Oaknin A, et al. Lancet. 2024 Jan 6;403(10421):31-43. doi: 10.1016/S0140-6736(23)02405-4. Epub 2023 Dec 1. Lancet. 2024. PMID: 38048793 Clinical Trial.
Noninvasive detection of microsatellite instability in patients with endometrial cancer.
Casas-Arozamena C, Moiola CP, Vilar A, Bouso M, Cueva J, Cabrera S, Sampayo V, Arias E, Abalo A, García Á, Lago-Lestón RM, Oltra S, Díaz E, Ruiz-Bañobre J, López-López R, Moreno-Bueno G, Gil-Moreno A, Colás E, Abal M, Muinelo-Romay L. Casas-Arozamena C, et al. Among authors: cueva j. Int J Cancer. 2023 May 15;152(10):2206-2217. doi: 10.1002/ijc.34435. Epub 2023 Jan 24. Int J Cancer. 2023. PMID: 36650670
Opportunities and Challenges for Antibodies against Intracellular Antigens.
Yang X, Xie S, Yang X, Cueva JC, Hou X, Tang Z, Yao H, Mo F, Yin S, Liu A, Lu X. Yang X, et al. Among authors: cueva jc. Theranostics. 2019 Oct 15;9(25):7792-7806. doi: 10.7150/thno.35486. eCollection 2019. Theranostics. 2019. PMID: 31695801 Free PMC article. Review.
Zoledronic acid in the treatment of metastatic breast cancer.
Lluch A, Cueva J, Ruiz-Borrego M, Ponce J, Pérez-Fidalgo JA. Lluch A, et al. Among authors: cueva j. Anticancer Drugs. 2014 Jan;25(1):1-7. doi: 10.1097/CAD.0000000000000020. Anticancer Drugs. 2014. PMID: 24100278 Review.
A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer.
Rodriguez-Casanova A, Costa-Fraga N, Castro-Carballeira C, González-Conde M, Abuin C, Bao-Caamano A, García-Caballero T, Brozos-Vazquez E, Rodriguez-López C, Cebey V, Palacios P, Cueva JF, López-López R, Costa C, Díaz-Lagares A. Rodriguez-Casanova A, et al. Among authors: cueva jf. Front Cell Dev Biol. 2022 Oct 25;10:1016955. doi: 10.3389/fcell.2022.1016955. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36393855 Free PMC article.
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.
Cueva JF, Palacio I, Churruca C, Herrero A, Pardo B, Constenla M, Santaballa A, Manso L, Estévez P, Maximiano C, Legerén M, Marquina G, de Juan A, Quindós M, Sánchez L, Barquin A, Fernández I, Martín C, Juárez A, Martín T, García Y, Yubero A, Gallego A, Martínez Bueno A, Guerra E, González-Martín A. Cueva JF, et al. Eur J Cancer. 2023 Mar;182:3-14. doi: 10.1016/j.ejca.2022.12.023. Epub 2022 Dec 29. Eur J Cancer. 2023. PMID: 36706655
CTCs Expression Profiling for Advanced Breast Cancer Monitoring.
Pereira-Veiga T, Martínez-Fernández M, Abuin C, Piñeiro R, Cebey V, Cueva J, Palacios P, Blanco C, Muinelo-Romay L, Abalo A, Costa C, López-López R. Pereira-Veiga T, et al. Among authors: cueva j. Cancers (Basel). 2019 Dec 4;11(12):1941. doi: 10.3390/cancers11121941. Cancers (Basel). 2019. PMID: 31817194 Free PMC article.
Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients.
Pereira-Veiga T, Bravo S, Gómez-Tato A, Yáñez-Gómez C, Abuín C, Varela V, Cueva J, Palacios P, Dávila-Ibáñez AB, Piñeiro R, Vilar A, Chantada-Vázquez MDP, López-López R, Costa C. Pereira-Veiga T, et al. Among authors: cueva j. Mol Cell Proteomics. 2022 Dec;21(12):100435. doi: 10.1016/j.mcpro.2022.100435. Epub 2022 Oct 28. Mol Cell Proteomics. 2022. PMID: 36519745 Free PMC article.
CTCs-derived xenograft development in a triple negative breast cancer case.
Pereira-Veiga T, Abreu M, Robledo D, Matias-Guiu X, Santacana M, Sánchez L, Cueva J, Palacios P, Abdulkader I, López-López R, Muinelo-Romay L, Costa C. Pereira-Veiga T, et al. Among authors: cueva j. Int J Cancer. 2019 May 1;144(9):2254-2265. doi: 10.1002/ijc.32001. Epub 2018 Dec 16. Int J Cancer. 2019. PMID: 30450632 Free article.
Novel therapeutic approaches to the treatment of metastatic breast cancer.
Fernández Y, Cueva J, Palomo AG, Ramos M, de Juan A, Calvo L, García-Mata J, García-Teijido P, Peláez I, García-Estévez L. Fernández Y, et al. Among authors: cueva j. Cancer Treat Rev. 2010 Feb;36(1):33-42. doi: 10.1016/j.ctrv.2009.10.001. Epub 2009 Nov 1. Cancer Treat Rev. 2010. PMID: 19883980 Review.
49 results